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ABSTRACT 
Gender Differences in Presenting Symptoms, Treatment, and 
Outcome in Myocardial Infarction 
by 
Alona Dalusung-Angosta 
Dr. Susan Kowalski, Examination Committee Chair 
Professor of Nursing 
University of Nevada, Las Vegas 
 The purposes of this study were to compare the presenting symptoms, treatment, 
and outcome between men and women with MI. The study sample consisted of 300 
patients (N = 300) who were diagnosed with MI in a county hospital in the Southwest 
area of the United States. 
  Chest pain, shortness of breath, sweating, and left arm pain were the most 
common symptoms reported by both genders. Men had more chest pain than their women 
counterparts (p = .022). No significant difference was found in the cardiac enzyme levels 
between both genders. Men had more Q wave changes during MI than women (p = .019). 
Women suffer MI two and a half years later than men (p = .004). Oxygen, nitrates, 
morphine sulfate, and heparin were the most common treatments given to men and 
women. Men received more morphine sulfate  (p = .013) and betablockers (p = .011) 
 than women in the emergency department. No significant difference was found in the 
coronary diagnostic and therapeutic procedures or outcome between both genders.  
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CHAPTER I 
 
INTRODUCTION 
 
Problem statement 
Recent studies in medical and nursing literature (Micevski, 1996 and Penque, et 
al., 1998) suggest that men and women present with different symptoms of myocardial 
infarction (MI). Furthermore, gender differerences in the treatment of MI and mortality 
outcome have been reported. However, the existing literature on gender differences in 
presenting symptoms, treatment, and outcome of MI is limited. The difference in the 
presenting symptoms, treatment, and outcome of MI in men and women needs to be 
further evaluated so that prompt and appropriate treatment will be provided to women as 
well as men experiencing an MI. This study seeks to add credibility to the existing 
literature on gender differences in presenting symptoms of MI.   
Background of the problem 
Coronary heart disease (CHD) is the single largest killer of men and women in the 
United States (American Heart Association, 1999). More men and women die from heart 
disease each year than from any other cause of death including cancer, accidents, 
pneumonia/influenza, and lung diseases (American Heart Association, 1999). Although 
recent CHD studies have included women, more information is needed regarding this 
deadly disease in relation to women.  
Women in the 1990s are dying of heart disease more often than men (American 
Heart Association, 1999). Recent research studies have indicated that mortality in women 
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is higher than in men following MI. Marrugat et al. (1998) studied mortality differences 
following MI in men and women. Their findings indicated that mortality after acute MI is 
greater in women than in men. A recent study by Vaccarino et al. (1999) reported similar 
findings and concluded that women have higher rates of death during hospitalization than 
men following MI. 
The American Heart Association (1999), the national standard source for 
cardiovascular disease, describes the common symptoms of MI. It does not address 
gender differences in the presenting symptoms of MI. The common symptoms of MI are 
uncomfortable pressure, fullness, squeezing, or pain in the center of the chest, pain that 
spreads to shoulders, neck, or arms, chest discomfort with lightheadedness, fainting, 
sweating, nausea, or shortness of breath. These symptoms are presented in most 
cardiovascular texts. Health care providers utilize these symptoms as guidelines for 
diagnosing MI.  
However, recent studies show that gender differences in presenting symptoms of 
MI exist. A recent study by Penque et al. (1998) noted that more women reported 
dyspnea, loss of appetite, and back pain than men. Chest pain was the common symptom 
reported by either gender. This finding is consistent with the results reported by Micevski 
(1996) who studied gender differences in the presenting symptoms of MI. In Micevski’s 
study, chest pain was the common symptom reported by both men and women. Men 
presented more often with diaphoresis and complaints of left and right arm pain; whereas, 
women presented more frequently with back pain/discomfort.  
Differences between men and women in their presenting symptoms may affect the 
treatment and evaluation of MI. Studies have reported the presence of a gender bias in the 
treatment and evaluation of patients with MI. Bergelson & Tommaso (1995) studied the 
differences in the clinical evaluation and treatment between men and women who 
presented with CHD. Their results indicated that women hospitalized with a coronary 
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diagnosis were less likely to undergo coronary arteriography than men. They further 
concluded that subjective interpretation of the symptoms and conditions prevented 
women from having coronary arteriography. Women who did undergo cardiac 
arteriography were more likely to be older. The latter finding was supported by Dellborg 
and Swedberg (1993) who noted that coronary angiography was performed more often in 
men than women during hospitalization. They concluded that women were older when 
referred for cardiac catheterization, coronary angioplasty, or coronary artery bypass 
surgery. Pharmacologic treatment for patients with MI was also given significantly less 
often in women than in men.  
In light of these issues, the need for further investigation on the differing 
symptoms of MI, treatment, and outcome in men and women is imperative. Mallory 
(1997) stated that if symptoms of MI remain unrecognized, patients may delay seeking 
medical treatment, and this could complicate their condition, possibly contributing to 
congestive heart failure. 
Significance of the problem 
It is of the utmost importance to educate nurses and other health care 
professionals as well as the public regarding the possible existence of gender differences 
in the presenting symptoms, treatment, and outcome in MI. Failure to recognize gender 
differences in the symptoms of MI can contribute to a delay in treatment and a higher 
mortality in women. Nurses play an important role in promoting health and in preventing 
and detecting diseases. The recognition of the signs and symptoms of patients with MI is 
imperative so that prompt and proper intervention, treatment, and management will be 
provided. 
Purpose of the study 
There are three purposes of this study. These are a) to compare the presenting 
symptoms of women and men who were diagnosed with MI in a county hospital in the 
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Southwest area of the United States b) to compare the treatments received by women and 
men with MI in the emergency department and c) to compare the outcome between 
women and men who were diagnosed with MI during hospitalization.  
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CHAPTER II 
 
REVIEW OF RELEVANT LITERATURE 
 
 
Introduction 
The literature on gender differences in presenting symptoms of myocardial 
infarction (MI) is quite sparse. These studies have not addressed the impact of gender 
differences in presenting symptoms on treatment and outcome of MI. Recent studies have 
focused on gender differences in treatment, management, and mortality of MI. This 
literature review addresses research studies and provides rationale and support for the 
present study. This chapter addresses coronary heart disease and the presenting symptoms 
of MI in general; impact of MI on women; gender differences in the presentation, 
treatment, management, and mortality of MI. The latter portion of the chapter identifies 
gaps in the literature and will provide a summary of the chapter. 
 
Coronary Heart Disease 
Since 1900, cardiovascular disease has been the leading cause of death each year 
in America (American Heart Association, 1999). One form of cardiovascular disease that 
leads to MI is coronary heart disease. Coronary heart disease (CHD) is caused by 
atherosclerosis, a narrowing of the vessel, due to the formation of lipid-laden lesions of 
the coronary arteries (McCance & Huether, 1998). This contributes to the interference of 
blood flow to the heart and can eventually result in MI, what is commonly known as a 
heart attack.  
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Myocardial Infarction 
Myocardial infarction results from CHD – blood vessel disease in the heart 
(American Heart Association, 1999). This definition of MI by the American Heart 
Association, a national organization for cardiovascular diseases and stroke, is commonly 
accepted and utilized in the literature. McCance and Huether (1998) define MI as the end 
point of CHD. MI occurs when there is prolonged ischemia to the heart muscle causing 
irreversible cellular death (Lewis & Collier, 1992). The diagnosis of MI depends on the 
physiological symptoms, presence of electrographic changes, and elevated cardiac 
enzymes.  
Presenting Symptoms of Myocardial Infarction 
The presenting symptoms of MI vary widely. The American Heart Association 
(1999) reports the signs and symptoms of MI with no distinction between women and 
men. These are uncomfortable pressure, fullness, squeezing, or pain in the center of the 
chest, pain that spreads to shoulders neck or arms, chest discomfort with lightheadedness, 
fainting, sweating, nausea, or shortness of breath. McCance and Huether (1998) describe 
the common symptoms of MI as chest pain that is heavy or crushing, chest pain with 
nausea and/or vomiting, diaphoresis, shortness of breath, or radiation to neck, jaw, back, 
or left-arm. Patients may complain of a feeling of weakness, severe indigestion, shortness 
of breath, or chest discomfort (Lewis & Collier, 1992). Others may complain of chest 
pain lasting more than twenty minutes and not relieved by nitroglycerin or rest, and it is 
characterized as deep, unrelenting pressure, ache, and squeezing sensation with nausea 
and/or vomiting, and diaphoresis (Fruth, 1991). 
Myocardial Infarction in Women 
Knowledge about the natural history of CHD in women was limited until recent 
years (Thomas & Braus, 1998). More women are dying of heart disease than from breast 
or lung cancers (American Heart Association, 1999). The mortality rate in women 
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following MI continues to be greater than for men. Marrugat et al. (1998) investigated the 
mortality in women following their first MI. A sample of 331 women and 1,129 men 
diagnosed with first MI, from 1992 through 1994, in four teaching hospitals in 
northeastern Spain was studied. They concluded that older women had more lethal and 
severe first MIs. The 28-day mortality rates were significantly higher among women 
(18% for women, 8.3% for men; p < .001). The 6-month mortality rates were 25% in 
women and 10.8% in men with a significant level of < .001. A recent study was 
conducted by Vaccarino, et al., (1999). A sample of 384,878 subjects (n = 155,565 
women, n = 229,313 men) who were enrolled in the National Registry of Myocardial 
Infarction Two (NRMI2) between the years of 1994 and 1998 was utilized in the study. 
The mortality rates were examined according to age group. They reported that younger 
women have higher rates of death after MI. The mortality rate during hospitalization was 
16.7% among women and 11.5% among men. The mortality rate for women less than 50 
years of age was more than twice as high than for men with a significant level of <. 001. 
The diagnosis of MI secondary to CHD presents a greater challenge in women. 
Recent evidence shows that women present different symptoms of MI. Perhaps this 
accounts for the less aggressive treatment received by women in the emergency 
departments who present with atypical symptoms of MI. A study was made to test this 
hypothesis. Heston et al. (1992) studied the evaluation and management of 445 patients 
(n = 246 women, n = 199 men) in ten emergency departments in St. Louis all of whom 
presented with acute chest pain. A record review was utilized in the study. Chi-square 
and t-tests indicated that men were initially evaluated by the physicians in the emergency 
department 30 minutes faster than women. Also, the initial electrocardiogram was 
performed 30 minutes earlier for men than for women. Steingart et al. (1991) investigated 
the management approach used with women who had MI. A sample of 389 women and 
1,842 men was utilized in the study. They found that physicians pursue a less aggressive 
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approach in treating women with MI despite their increased cardiac disability. This study 
shows that emergency department physicians did not diagnose women as quickly as men 
who presented with symptoms of MI, thereby delaying appropriate and early medical 
intervention critical to their successful treatment and outcome. 
Gender Differences in the Presentation of MI 
Recent studies show the presence of gender differences in the clinical presentation 
of MI. Micevski (1996) studied the differences in the presenting symptoms of MI in 115 
men and 115 women. Chi-square and t-tests showed that chest pain was the common 
symptom reported by both men and women. Men presented more often than women with 
diaphoresis (p < .0001) and with complaints of right arm pain (p < .03); whereas, women 
presented more frequently with back pain/discomfort (p = .01). The limitation of this 
study was the use of a small sample population.  
A study conducted by Penque et al. (1998) also examined the differences in 
presenting signs and symptoms of MI on 98 patients (n = 51 women, n = 47 men). 
Structured interviews and chart audits were utilized in the study. Using descriptive 
statistics and chi-square analysis, they found existing differences between women and 
men. Women were more likely to present with back pain, paroxysmal dyspnea, and loss 
of appetite than men. The limitations of their study were the use of convenience sampling 
and again, a small sample.  
Meischke, Larsen, and Eisenberg (1998) investigated gender differences in acute 
myocardial infarction symptom presentation. A sample consisted of 4,497 patients (n = 
1,527 women, n = 2,970 men) diagnosed with acute myocardial infaction.These patients 
were consecutively included in the study. Their findings showed that gender differences 
in symptom presentation do exist. A chi-square analysis indicated that men reported chest 
pain and diaphoresis more often than women.  Women reported more shortness of breath, 
nausea, and vomiting than men. The weaknesses of this study are the method used for 
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coding of symptoms and the unequal sampling of women and men with MI. 
Gender Differences in Treatment and Management of MI 
Recent studies show women and men who present with MI are treated and 
managed differently. Women were less likely to be referred for coronary angiography, 
percutaneous transluminal coronary angioplasty (PTCA), and coronary arterby bypass 
graft (CABG). Steingart et al. (1991) examined the difference in the management of 
coronary artery disease between men and women. A total of 2,231 subjects (n = 389 
women, n = 1,842 men) with acute myocardial infarction were enrolled in the Survival 
and Ventricular Enlargement (SAVE) study. The SAVE trial was conducted at 112 
hospitals in the United States and Canada. Patients were enrolled in the study from 
January 1987 to January 1990. Chi-square analysis and multiple logistic regression 
showed that women were less likely to be referred for cardiac catheterization than men. 
Also, women underwent CABG less often than men. The study was conducted in more 
than one hospital and had a large sample population. These latter factors give strength to 
the study findings. Dellborg and Swedberg (1993) did a similar study. They examined the 
difference in treatment between men (n = 1,022) and women  (n = 493) with MI. The t-
test results showed that coronary angiography was performed significantly more often in 
men than in women (p < 0.001).  
Research studies documented issues regarding coronary revascularization 
between men and women. Women who are referred for coronary revascularization such 
as PTCA and CABG tend to be older and sicker (Eysman & Douglas, 1993). Khan, et al. 
(1990) investigated the differences in referral for CABG between men and women. A 
total of 2,297 patients (n = 482 women, n = 1,815 men) were consecutively selected in 
the study. Data were collected using chart review. Two-sample t-tests and chi-square 
analysis indicated that women were referred for CABG later in the course of their disease 
than men. Women were significantly older than men (68.2 compared with 64.0 years, p < 
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0.001). A limitation is that the authors did not examine the course and outcome of women 
and men who were not referred for CABG.  
Maynard et al. (1992) examined the differences in treatment and outcome of acute 
myocardial infarction in 4,891 patients (n =1,659 women; n = 3,232 men) in the Seattle 
metropolitan area between the years of 1988 and 1990. A record review was utilized in 
the study. Chi-square and t- test analyses showed that women were less likely to undergo 
cardiac catheterization, to have PTCA, or to have CABG than men.  
Gender Differences in Evaluation for MI 
As mentioned previously, Heston et al. (1992) studied the evaluation and 
management of 246 women and 199 men in ten emergency departments. They reported 
that women were evaluated and managed less aggressively than men. Their findings 
indicated that men were seen and assessed by emergency department physicians 30 
minutes faster than women. 
Gender Differences in Pharmacological Treatment 
The issue of gender bias in pharmacological treatment of MI in women and men 
has also been investigated. Dellborg and Swedberg (1993) examined a total of 1,515 
patients (n = 493 women, n = 1,022 men) diagnosed with MI in a community hospital in 
Sweden between 1989-1991. Using the t-test, they found that men were more likely to 
receive thrombolytic drugs (34% vs 24%), intravenous nitroglycerin (41% vs 33%), and 
intravenous betablockers (36% vs 27%) than women. However, inotropic drugs such as 
dobutamine and dopamine were given more often to women (14% vs 8%) than to men.  
Ryan et al. (1996) reported that early administration of thrombolytic therapy on 
patients with AMI results in improved left ventricular systolic function and survival. 
However, gender differences occur in the administration of thrombolytic therapy. 
Yarzebski et al. (1996) conducted a study on thrombolytic therapy on 1,680 men and 
1,205 women with confirmed acute MI. Data were collected from 16 hospitals in 1986, 
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1988, 1990, and 1991. Their findings showed that thrombolytic use in men increased by 
127% from 1986 to 1991 and continued to increase after that period. In contrast, 
thrombolytic use in women increased from 3.2 % in 1986, 12.8% in 1988, 22.2 % in 
1990, and then declined to 19.0 % in 1991 and did not increase further.   
Gender Differences in Mortality 
In addition to treatment differences, there is also documentation of increased 
mortality for women compared to men with MI. As mentioned previously, Khan et al. 
(1990) studied in-hospital mortality rates for women (n = 482) and men (n = 1,815) who 
had CABG. The findings of the study showed that women had higher mortality rates than 
men following CABG (4.6 % for women and 2.6 % for men). Maynard et al. (1992) also 
investigated this issue on 4,891 patients (n = 1,659 women and 3,232 men). They 
reported that hospital mortality after CABG was higher for women than for men (16 % 
for women and 11 % for men before age adjustment). These authors reported that even 
after age adjustment, the risk of hospital mortality following CABG was still higher for 
women.  
Vacarrino et al. (1998) studied the impact of gender and age with respect to short-
term mortality after MI. They found that the mortality rate of women who were younger 
than 75 years old was twice than that of men in the same age group. No differences were 
found in mortality between women and men who were over 79 years of age following 
MI. A weakness of this study is its small sample size of 52 women and 45 men. A more 
recent study conducted by Vaccarino et al. (1999) investigated differences in early 
mortality after MI in men and women. This study utilized a large sample consisting of 
384,878 subjects who had experienced MI (n = 155,565 women, n = 229,313 men). The 
study was conducted between 1994 and 1998. Using bivariate analyses, the study 
findings were similar to the authors’ previous study. The overall mortality rate during 
hospitalization was higher among women (16.7 %) than among men (11.5 %). These 
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researchers reported that the mortality of women younger than 50 years of age was more 
than twice that for men. This research reveals that not only older women have higher 
mortality rates following MI, but also younger women have significantly higher mortality 
rates than men.  
A recent study conducted by Hochman et al. (1999) examined gender differences 
in presentation and outcome on 12,142 patients (n = 3,662 women, n = 8,480 men) with 
acute coronary syndromes. Multivariate logistic regression and chi-square tests showed 
that women had more complications than men during hospitalization and a significantly 
higher mortality rate (p <.001) than men at 30 days (6% vs 4%). 
 
Gaps in the Literature 
A review of the literature indicates that there are only a few recent studies that 
address gender differences in the presenting symptoms, treatment, and outcome of MI. 
These studies utilized small or uneven sample population and did not address whether the 
differences in the presenting symptoms of MI in men and women have an impact on the 
treatment and outcome. Additional studies on gender differences in presenting symptoms, 
treatment, and outcome of  MI would add credibility to the existing literature. 
 
Summary 
The review of the literature demonstrates that CHD is the leading cause of death 
in women and in men (American Heart Association, 1999). Studies on the presenting 
symptoms of MI between women and men were reviewed. The American Heart 
Association (1999), McCance & Huether (1998), Lewis & Collier (1992), and Fruth 
(1991) reported the signs and symptoms of MI with no distinction between women and 
men. In contrast, Micevski (1990); Penque et al. (1998); and Meischke et al. (1998) 
reported the presence of gender differences in the presenting symptoms of MI. They 
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noted that women presented with backpain, dyspnea, loss of appetite, nausea, and 
vomiting; whereas, men presented more  often with diaphoresis, complaints of right arm 
pain, and chest pain. The need for further research on the differences in symptoms of MI 
has been noted. 
Studies on the differences in treatment for MI between women and men have also 
been reviewed. Numerous studies have been noted regarding gender bias in coronary 
revascularization between women and men. Hsia (1993), Steingart et al. (1991), Dellborg 
& Swedberg (1993), and Maynard et al. (1992) reported that women were less likely to 
be referred for coronary angiography than men; women underwent PTCA and CABG less 
often than men. Dellborg & Swedberg (1993) and Ryan et al. (1990) noted that not only 
coronary revascularization treatment differs in women and men, but also gender bias in 
the pharmacological treatment was also noted. Men were more likely to receive 
thrombolytic drugs, nitroglycerin, and betablockers than women.   
Studies on gender differences in patients’ outcome with MI during hospitalization 
were also discussed. Khan et al. (1990) and Maynard et al. (1990) reported that women 
had higher hospital mortality rates than men following CABG. Women had more 
complications and had higher mortality rates than men following MI as reported by 
Vacarrino et al. (1998) and Hochman et al. (1999). A more recent study by Vacarrino et 
al. (1999) was also reviewed. They noted that not only older women have higher 
mortality rates following MI, but also younger women have significantly higher mortality 
rates than men. 
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CHAPTER III 
 
FRAMEWORK 
 
Introduction 
This study utilizes the Neuman’s Systems Model. This conceptual model has a 
wholistic focus and is ideal for guiding this study. The two major concepts of the 
Neuman’s Systems Model are stressors and the reactions to such stressors. According to 
Neuman (1995), the person has a certain “degree of reaction” to any given stressor at any 
given time. This conceptual model, developed by Dr. Betty Neuman in 1972, is presently 
recognized and frequently used within the discipline of nursing. This chapter discusses 
the conceptual framework, application of the Neuman Systems Model, propositions, 
hypotheses, variables of the study, definition of variables, and concludes with a chapter 
summary. 
 
Conceptual Framework 
   In the Neuman’s Systems Model, the client or client system (patient) is viewed as 
multidimensional and wholistic. The client is composed of five simultaneously 
interacting variables. These variables are physiological, psychological, sociocultural, 
developmental, and spiritual factors. The client is represented by a series of broken rings 
surrounding the basic core structure (Neuman, 1995). The basic core structure consists of 
all survival factors and is protected by the flexible line of defense and the lines of 
resistance. (See Figure 1). These lines of resistance surround the core structure and serve 
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as a protective mechanism for the client system’s integrity. The client’s usual state is 
represented by a solid line called the normal line of defense. The lines of resistance are 
activated when the normal line of defense is disrupted by environmental stressors, such as 
MI, which causes irreversible damage to the heart muscle. When the normal line of 
defense is disrupted, reactions (symptoms) occur such as chest pain or nausea /and 
vomiting. Neuman (1995) identifies the flexible line of defense as dynamic, and it serves 
as a protective buffer for preventing stressors from penetrating the normal line of defense.  
  Environment is defined as “all internal and external factors or influences 
surrounding the identified client or client system” (p.30). According to Neuman (1995), 
the client may be influenced either positively or negatively by environmental forces. 
These environmental forces are called stressors, and they can penetrate the flexible and 
normal lines of defense. Stressors are classified as intrapersonal, interpersonal, and 
extrapersonal. Many environmental factors contribute to the development of MI, such as 
a high cholesterol diet or a stressful job. Myocardial infarction is an example of 
intrapersonal stressor. Information regarding the symptoms of MI shared by the nurses to 
the patients is an example of an interpersonal stressor. Loss of a job due to physical 
disability secondary to MI is an example of extrapersonal stressor. 
Health is a state of optimal wellness or system stability (Neuman, 1995). Optimal 
wellness or stability indicates that all a person’s needs are being met. According to 
Neuman, optimal wellness is the condition in which all five variables are in harmony 
with the whole system, which determines the resistance of a person to any stressor.  
Nursing is concerned with all variables affecting the patient’s response to stress. 
Nursing interventions focus on primary, secondary, and tertiary preventions (Neuman, 
1995). According to Neuman (1995), these three levels of prevention are important to the 
patient prior to, during, and following the event of MI. (See Figure 1). A patient with MI 
may also require an intervention in all three areas of prevention simultaneously.  
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As illustrated in Figure 1, the goal of primary prevention is to strengthen the 
patient’s flexible line of defense and to protect the normal line of defense or usual state. 
This is accomplished by educating the health care professionals and the public based on 
the findings of this study. The goal of secondary prevention is to strengthen the lines of 
resistance by providing appropriate treatment of symptoms to all patients with MI in 
order to attain optimal wellness and stability. Interventions in secondary prevention 
require prompt assessment that includes recognizing the different symptoms of MI in 
men and women and providing appropriate treatment. “If secondary prevention as 
intervention fails to reconstitute the patient, death occurs as a result of failure of the basic 
structure to support the intervention” (p.34). Tertiary prevention is used for wellness 
maintenance. The goal of tertiary prevention is “to maintain an optimal wellness level” 
(Neuman, 1995). Educating patients who have had MI regarding the symptoms of the 
disease, lifestyle changes that will prevent or reduce their chance of having a second MI, 
and cardiac rehabilitation, following MI are examples of tertiary prevention.  
Application of the Neuman Systems Model 
MI is a stressor that affects the patient’s physiological, psychological, 
sociocultural, developmental, and spiritual being; causing system instability. The 
patient’s flexible and normal lines of defense have been disrupted by MI as manifested by 
their presenting symptoms (stress reaction) such as chest pain; nausea; shortness of 
breath; diaphoresis; and chest pain with radiation to jaw, neck, arms, shoulders, and back; 
the presence of electrographic changes; and elevated cardiac enzyme levels. (See Figure 
2). Recognition of symptoms and treatment of MI will stabilize the patients 
physiologically and psychologically, thus preventing a negative impact on their 
sociocultural, developmental, and spiritual beings. 
Nurses and other health practitioners need to recognize the differing symptoms of 
women and men who are experiencing MI so that faster and more appropriate treatment 
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will be provided. Treatment of symptoms such as “immediately giving oxygen, 
sublingual nitroglycerin, analgesia, and aspirin will improve the patient’s left ventricular 
systolic function and survival ” (Ryan et al., 1996). If symptoms are recognized, and if 
appropriate treatments and procedures are provided, patients are protected from further 
illness or death.  
 
Propositions 
The present study proposes that women and men respond to the stressors of MI 
differently. This study also proposes that gender differences exist in treatment and 
outcome of MI. Because the differences in presenting symptoms of MI can affect the 
treament and outcome of patients, this research proposes that the recognition of the 
different responses to stressors in women and men with MI can lead to a faster and more 
appropriate treatment. These factors can influence the high mortality rates in women. 
 
Hypotheses 
The following hypotheses direct this study. 
1. There is a gender difference in the presenting symptoms of patients with MI in 
the emergency department.  
2. There is a gender difference in the cardiac enzyme levels and electrographic 
changes on patients with MI who present to the emergency department.  
3. There is a gender difference in the mean age of patients who experience their 
first MI. 
4. There is a gender difference in the treatment received by patients with MI in the 
emergency department. 
5. There is a gender difference in the outcome of patients with MI during 
hospitalization. 
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6. There is a gender difference in the coronary diagnostic and therapeutic 
procedures on patients with MI during hospitalization. 
 
Definitions of Variables 
The following definitions are used in the study for the selected variables. 
Myocardial Infarction 
 The conceptual definition of MI is “prolonged ischemia to the heart muscle 
causing irrevesible cellular death” (Lewis & Collier, 1992). The operational definition of 
MI is the discharge diagnosis of MI on the patient’s chart.  
Gender 
Conceptually, gender is defined as a person’s sex. Operationally, gender is the 
recorded letter (M for male, F for female) for the subject in the study.  
Cardiac Enzymes 
Conceptually, cardiac enzymes are the enzymes contained within the heart muscle 
cells that are released when the heart muscle is damaged (Pagana & Pagana, 1990). The 
operational definition of cardiac enzymes is the documented results of CKMB fractions 
greater than 4 ng/dL for both men and women as recorded in the laboratory results 
section of the patient’s chart. CKMB values are based on the facility’s protocol where the 
study was conducted. 
Electrocardiographic Changes 
Conceptually, electrocardiographic changes are the changes in the electrical 
activity of the heart. The operational definition of electrographic changes is the 
documented evidence of pathologic Q wave, changes in ST segments, or changes in T 
waves as recorded in the patient’s chart by the emergency department physician. 
Presenting Symptom  
Conceptually, the presenting symptom is the symptom that causes the individual 
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to seek medical attention and that leads to a diagnosis of MI (Micevski, 1996). 
Operationally, presenting symptoms are the symptoms of MI described by the American 
Heart Association (1999) such as uncomfortable pressure, fullness, squeezing, or pain in 
the center of the chest, pain that spreads to shoulders, neck, or arms, chest discomfort 
with lightheadedness, fainting, sweating, nausea, or shortness of breath. Presenting 
symptoms as described by Micevski (1996) include intrascapular pain, jaw pain, back 
pain or discomfort, abdominal pain or discomfort (Micevski, 1996)). 
Treatment  
            The conceptual definition of treatment is the intervention provided to patients at 
presentation for treatment of MI in the emergency department to attain system stability or 
wellnes and energy conservation (Neuman, 1995). The operational definition of treatment 
is the documented use of oxygen, aspirin, nitrates, morphine sulfate, thrombolytics, 
heparin, beta-blockers, and ace inhibitors on patients experiencing an MI.These are 
recorded in the emergency department sheet, nurses’ notes, and physician’s order sheet. 
Outcome  
The conceptual definition of outcome is the result or effect of an event (Ehrlich et 
al., 1980). The operational definition of outcome is the documented length of stay in the 
hospital or death.  
Coronary Diagnostic and Therapeutic Procedures 
The conceptual definition of coronary diagnostic and therapeutic procedures is the 
intervention provided to patients with MI during hospitalization. Operationally, coronary 
diagnostic and therapeutic procedures are coronary angiogram, percutaneous transluminal 
coronary angioplasty (PTCA), and coronary artery bypass garft (CABG) as documented 
in the physician’s progress notes, history and physical sheet, and nurse’s notes. 
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Summary 
This chapter presented the Neuman’s Systems Model. This nursing model served 
as the conceptual framework for this study. Application of the Neuman Systems Model to 
the present study, propositions of the study, and the six hypotheses were addressed. The 
chapter concluded with the definition of variables.  
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CHAPTER IV 
 
METHODS AND PROCEDURES 
 
Introduction 
The purposes of this study are three fold a) to compare the presenting symptoms 
of women and men who are diagnosed with MI b) to compare the treatments received by 
women to those received by men who were diagnosed with MI in the emergency 
department and c) to compare the difference in outcome of women and men during 
hospitalization. This chapter includes a discussion of the research design, study sample, 
measurement strategies, data collection procedure, and statistical analyses. 
 
Research Design 
The research design that was utilized in this research study is comparative 
descriptive design. This particular design was appropriate for the study because the 
characteristics of the subjects were described but were not manipulated by the researcher. 
Further, there was no research treatment or intervention involved in the study, no 
causality examined; and the differences in variables (presenting symptoms of MI and 
treatments) between the two groups (women and men) were investigated.  
 
Sample 
The target population in this study encompassed both women and men diagnosed 
with MI. The accessible population consisted of women and men with a confirmed 
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diagnosis of MI who were admitted to a county hospital in the Southwest area of the 
United States during the years of 1998-2000.  
The sampling criteria included women and men admitted in the emergency 
department via ambulance or through the emergency department’s triage area to rule out 
MI or unstable angina and who had a discharge or final diagnosis of MI. Other criteria for 
the study included patients between the ages of 35 to 65 years old and who had their first 
MI. Patients who died in the hospital following MI were also included in the study. 
Patients who have had a previous MI were excluded from the study. Based on the 
information obtained from the facility’s medical records department where the study was 
conducted, the age range for the majority of patients who have their first MI is between 
35-65 years old. Patients over 65 years old were excluded in this study because they tend 
to have other accompanying diseases that may have an influence on MI. 
Power analysis was used to estimate the study’s sample size. To control for Type 
II error, an 80% power level is desirable (Burns & Grove, 1997). If power is high, it 
strengthens the meaning of the findings (Polit, 1996). A sample of 300 patients (n = 150 
women, n = 150 men) was needed to achieve a power of .80 with an alpha set at .05 in a 
2-tailed test. This number of patients in the sample allowed for a small effect size (Polit, 
1996). There  was a sufficient number of patients that were included in the study. The 
facility where the study was conducted admits approximately 600-700 patients with MI a 
year. The subjects in the study were selected randomly by choosing every other subject 
from the hospital’s computer listing. The study design was strengthened by this sampling 
method.  
Permission to conduct this study was obtained from the researcher’s thesis 
committee, the Department of Nursing, and the Human Subjects Rights’ Committee for 
The University of Nevada, Las Vegas (UNLV). Written approval to conduct the study 
was obtained from the facility’s Nursing Administration. The consent forms were  
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approved by the Director of Nursing, the Director of Staff Development, and the Director 
of Health and Information Systems and was submitted to the UNLV’s Human Subjects 
Rights’ Committee. To ensure patient confidentiality, patients’ names were not used in 
the present study; letters and number codes were used instead. (See Appendix D). 
 
Measurement Strategies 
The Gender MI Data Collection Tool (GMIDCT) was compiled by the author to 
collect data in the present study. The GMIDCT consists of four sections: demographics, 
cardiac markers, presenting symptoms, and treatment received. (See Appendix C). 
Demographics: 
The first part of the GMIDCT are the demographics. This includes the patient’s 
identification code, gender, date of admission, date of discharge, age, and death.  
Cardiac Markers: 
 This is the second part of the GMIDCT. Cardiac markers include electrographic 
changes and cardiac enzymes. The electrographic changes are measured by the presence 
or absence of Q wave changes, ST segment changes, and T wave changes. Cardiac 
markers include the recorded value of CKMB fraction. CKMB values are based on the 
facility’s protocol where the study was conducted. 
Presenting Symptoms: 
   The third part of the GMIDCT is the presenting symptoms of MI. The 
presenting symptoms include uncomfortable pressure, fullness, squeezing, pain in the 
center of the chest, pain spreading to shoulders, pain in the neck, pain in right arm, pain 
in left arm, nausea, sweating, shortness of breath, fainting, chest discomfort with 
lightheadedness, intrascapular pain, right jaw pain, left jaw pain, mid upper back 
pain/discomfort, lower back pain/discomfort, and abdominal pain/discomfort.  
This section of the data collection tool is based on Micevski’s (1996) Presenting 
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Symptoms’ Data Collection Tool for MI and Mallory’s (1997) American Heart 
Descriptors of MI. Consent has been obtained from the authors to use these tools (See 
Appendix D). Micevski’s (1996) data collection tool demonstrated content-related 
validity and Mallory’s (1997) data collection tool demonstrated inter-rater reliability.  
Treatment Received 
The fourth part of the GMIDCT is the treatment received or not received by 
women and men experiencing MI in the emergency department. This includes oxygen, 
aspirin, nitrates, morphine sulfate, thrombolytics, heparin, betablockers, and ace 
inhibitors. Interviews with four practicing emergency department physicians confirmed 
that these treatments are most commonly given in the emergency department for MI 
patients. In addition, these treatments are based on the most recent national guidelines for 
the management of patients with acute myocardial infarction as developed by the 
American College of Cardiology/American Heart Association’s Task Force Committee 
on Management of Acute MI (Ryan et al., 1996).  
Coronary Diagnostic and Therapeutic Procedures 
The fifth part of the GMIDCT is the coronary diagnostic and therapeutic 
procedures received by patients with MI. The coronary diagnostic and therapeutic 
procedures include coronary angiogram, PTCA, and CABG. 
The GMIDCT was reviewed by one cardiologist, four practicing emergency 
department physicians, and one clinical nurse specialist, with a specialty in cardiology.  
 
Procedure for Data Collection 
The researcher reviewed the randomly selected patients’ charts in the hospital’s 
medical records department. Records from January 1, 1998 to July 1, 2000 were 
examined. The following procedures were used for data collection. First, patient 
information was entered in the hospital’s computer by the medical records’ supervisor. 
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Information that was entered in the computer included patient’s medical diagnosis, using 
the number code for MI; gender; age; date of admission; and date of discharge. Second, 
upon entering the information, the medical records’ supervisor obtained a computer 
printout, which she then gave to the researcher. Third, the researcher randomly selected 
the patients by choosing every other subject from the hospital’s computer printout list 
until 300 patients (150 women and 150 men) were obtained. The random selection 
process began by using a coin flip. The coin head was labeled number 1 and the coin tail 
was labeled number 2. The researcher obtained the tail after the coin flip, the count 
started on patient number 2. The reseacher then chose every other subject from the 
computer printout list until 300 subjects (150 women and 150 men) were obtained. 
Fourth, after random selection, the researcher coordinated with the medical records’ staff 
to obtain patients’charts. Fifth, the charts retrieved by the medical records’ staff were 
given to the researcher to be examined.  
A total of twenty charts a day were reviewed. No more than twenty charts were 
examined at a time to decrease error in data collection. A research assistant was utilized 
to assist with data collection. This research assistant was a licensed registered nurse who 
had a specialty in cardiology and who had a background in research study. Inter-rater 
reliability was established by having the research assistant read the same charts (10 
charts) that the researcher had already examined to ensure the information obtained from 
the charts was correct.  
The demographics were collected from the patient’s chart as listed on the 
paramedic’s sheet, history and physical sheet, and hospital’s “face” sheet. Cardiac 
enzymes were obtained from the laboratory section of the patient’s chart. Information on 
the electrocardiogram was obtained from history and physical sheet or physician’s 
progress notes. Presenting symptoms were collected from the history and physical sheet, 
nurse’s notes, or physician’s progress notes. Information on treatment received was 
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collected from emergency department sheet, physician’s order sheet, and nurse’s notes.  
 
Statistical Analyses 
Hypotheses 
The following hypotheses provided a direction for the analysis of study data. 
1. There is a gender difference in the presenting symptoms of patients with MI in 
the emergency department. 
Frequency distributions and chi-square analysis were used for hypothesis one. 
Frequency distributions organize the data allowing for examination. Further, they are 
used to examine errors in coding and computer programming (Burns & Grove, 1997). By 
using frequency distribution, the researcher was able to identify which symptoms of MI 
occured most often in men and women, which symptoms were common to both groups, 
who had more symptoms, and how many subjects there were in total. Before analyzing 
the data, it was checked for error using frequency command in the Statistical Package for 
the Social Sciences (SPSS) program. Chi-square analysis was appropriate for this 
hypothesis because the data were categorical (nominal level). Chi-square tests for the 
differences in frequencies of observed data and compares them with the expected 
frequencies (Burns & Grove, 1997). The presenting symptoms were listed as present or 
not present. The observed frequencies in each group were compared with the frequencies 
expected. A critical value and a level of significance (set at .05) was included and was 
obtained in order to support that a statistical difference existed between men and women 
in their presenting symptoms. A 2 x 2 chi-square table was used. 
2. There is a gender difference in the cardiac enzyme levels and electrographic 
changes on patients with MI who present to the emergency department. 
The t-test for independent groups was chosen for hypothesis two because the 
outcome data and cardiac enzyme levels, were at interval level. This test analyzes the 
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difference between two means (Polit, 1996). The difference between the means of women 
and men were analyzed regarding cardiac enzyme levels. A significance of .05 was 
established.  
Chi-square analysis was selected for hypothesis two because the data, 
electrographic changes, were at nominal level. The electrographic changes were listed as 
present or not present. The observed frequencies in each group were compared with the 
expected frequencies. A resulting chi-square co-efficient with a .05 level of significance 
or less would indicate that a difference exists between women and men in their 
electrographic changes.  
3. There is a gender difference in the mean age of patients who experience their 
first MI. 
The t-test analysis was also chosen for hypothesis three. The difference between 
the means for each group was analyzed regarding age. A significance level of .05 was 
established. 
4. There is a gender difference in the treatment received by patients with MI in the 
emergency department. 
            Frequency distribution was appropriate for hypothesis four. This method gave 
information on the total number of treatments, types of treatment received by men and 
women, and who received the most treatments. Chi-square analysis was also chosen for 
hypothesis four because the data were categorical (nominal level data). The treatments 
were listed and were measured as given or not given. The frequencies in each group were 
compared with the expected frequencies. A resulting chi-square co-efficient with a .05 
level of significance or less would indicate that there is a difference between women and 
men regarding the treatments they received. Again, a 2 x 2 chi-square was used for each 
treatment. 
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 5. There is a gender difference in the outcome of patients with MI during 
hospitalization. 
         The t-test for independent groups was appropriate for hypothesis five because the 
length of days until discharge was at the interval level. A significane of .05 was 
established. In addition, a chi-square was computed regarding the outcome of death, 
living discharge, and gender. 
6. There is a gender difference in the coronary diagnostic and therapeutic 
procedures on patients with MI during hospitalization. 
Frequency distribution was used for hypothesis six. Again, by using this method, 
the researcher was able to identify the total number of coronary diagnostic and 
therapeutic procedures, the types of procedure, which procedures were performed more 
frequently, which procedures were common to both groups, and who received the 
common procedure.  
          The above mentioned statistical analyses were performed by the researcher on the 
computer using the SPSS software. The data was summarized with a discussion of the 
results for each hypothesis. The results were presented in tables and figures.  
 
Methodological Limitations 
The limitations of this study included the following a) the sample was drawn from 
only one hospital in one geographic area which limited its generalizability; b) the 
patient’s documented complaints (presenting symptoms) may have been influenced by 
the interviewer’s bias prior to or at the time of hospitalization; c) hospital records may 
have not reflected actual information.  
 
Summary 
This chapter discussed the proposed research design and sampling procedures. 
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Measurement strategies, data collection procedures, and proposed data analysis for each 
of the six hypotheses were also addressed. The chapter concluded with a discussion of 
methodological limitations.
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CHAPTER V 
 
DATA ANALYSIS 
 
Introduction 
This chapter summarizes the results of the study and its findings. Statistical 
analysis used in addressing the six hypotheses which directed this study are presented. 
The Statistical Package for the Social Sciences (SPSS) software was the program used to 
analyze the study data using frequency distributions, chi-square tests, and t-tests.  
 
Description of Sample 
The population sample consisted of 300 patients (N = 300) who were diagnosed 
with MI. The sample had equal representation of women (n = 150) and men (n = 150). 
Data were collected through chart review in a county hospital in the Southwest area of 
the United States from January 1, 1998 to July 1, 2000. The age of the sample population 
ranged from 27 to 65 years old. The mean age was 53.7 years old with a standard 
deviation of 7.65 years. The median age was 47 years old and the mode was 55 years old. 
(See Figure 3). 
 
Reliability Analysis 
The data collection tool that was utilized in the present study was compiled by the 
author. The Gender MI Data Collection Tool (GMIDCT) is based on Micevski’s (1996) 
Presenting Symptom’s Data Collection Tool for MI and Mallory’s (1997) American 
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Heart Descriptors of MI. Mallory’s data collection tool demonstrated an inter-rater 
reliability of .90.  
Inter-rater reliability was established for the GMIDCT by having a research 
assistant read a total of ten charts that the researcher had already reviewed and coded. A 
comparison of the agreements obtained between the researcher and the research assistant 
on the coding form with number of possible agreements was calculated. A score of 97.3% 
agreement was obtained. This presented support for inter-rater reliability of the 
GMIDCT. 
 
Results of the Hypotheses 
The following are the results of analysis pertaining to each hypothesis.  
Hypothesis 1 
“There is a gender difference in the presenting symptoms of patients with MI in 
the emergency department.” 
The first hypothesis was analyzed using frequencies. Chest pain was a common 
symptom on presentation as well as shortness of breath, sweating, and left arm pain for 
both men and women in the emergency department. However, men presented with chest 
pain more often than women (92% vs 83.3%). Women tended to present with nausea 
more frequently than men (40% vs 30.9%). Women also demonstrated a more frequent 
presence of mid upper back pain more often than men (10.7% vs 5.3%). (See Table 1).  
To examine the difference of each of the presenting symptoms between men and 
women, a chi-square analysis was utilized. The only significant difference in symptoms 
between men and women was chest pain (X2 = 5.210, p = .022). The symptoms that are 
close to significance were nausea (X2 = 2.859, p = .091) and mid upper back pain (X2 = 
2.899, p = .089). (See Table 2). 
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Hypothesis 2 
“There is a gender difference in the cardiac enzyme levels and electrographic 
changes on patients with MI who present to the emergency department.” 
The t-test was used to examine the difference between the two groups. The mean 
cardiac enzyme level for women was 32.57 with a standard deviation of 72.45. The mean  
cardiac enzyme level for men was 42.32 with a standard deviation of 107.76. 
No significant difference in the cardiac enzyme levels was indicated between women and 
men with MI (t = .920, p = .358). (See Table 3). Mann Whitney U-test was also 
performed for hypothesis two. No significant difference was found in the cardiac enzyme 
levels between men and women (Z = -1.010, p = .313). 
Electrographic changes were analyzed using frequencies. Men presented with Q 
wave changes more often than women (21.3% vs 11%). (See Table 4).  A chi-square 
analysis was computed to examine the difference in electrographic changes between men 
and women. The only significant difference in the electrographic changes between men 
and women was the Q wave (X2 = 5.488, p = .019). There was no significant differences 
in T wave (X2 = .059, p = .807) or ST segment (X2 = .887, p = .346) on the 
electrocardiograph. (See Table 5). 
Hypothesis 3 
“There is a gender difference in the mean age of patients who experience their 
first MI.” 
T-test results (t = -2.880, p = .004) indicate that there is a significant gender 
difference in the mean age of patients who experience their first MI. The mean age for 
women was 54.99 years old with a standard deviation of 7.57 years. The mean age for 
men was 52.47 years with a standard deviatin of 7.55 years. (See Table 6). 
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Hypothesis 4 
“There is a gender difference in treatment received by patients with MI in the 
emergency department.” 
Hypothesis four was analyzed using frequencies. Oxygen, nitrates, heparin, 
aspirin, and morphine sulfate were the common treatments given to both genders. 
However, men tended to receive morphine sulfate more often than women (47.0% vs 
33.3%) in the emergency department. Men also received betablockers more often than 
women (24.0% vs 12.7%). Furthermore, men received aspirin more frequently than 
women (50.0% vs 40.7%). Nitrates were given to men more frequently than to women 
(90.7% vs 84.0%). (See Table 7). 
A chi-square analysis was employed to examine the difference in treatment for MI 
received by men and women in the emergency department. A significant difference was 
found between the two groups. Morphine sulfate and betablockers were given more often 
to men than to women (X2 = 6.108, p = .013; X2 = 6.434, p = .011). (See Table 8). 
Hypothesis 5 
“There is a gender difference in the outcome of patients with MI during 
hospitalization.” 
Length of stay was analyzed using frequencies and t-test. The average length of 
stay for men in the hospital was 6.48 days. The median was 5 days with a standard 
deviation of 3.61 days. The maximum length of stay in the hospital for men was 25 days. 
The mean length of stay for women was 7.17 days. The median was 5 days with a 
standard deviation of 6.09 days. The maximum length of stay for women in the hospital  
was 57 days. T-test results indicate that there is no significant difference in the length of 
stay between men and women with MI (t = -1.187, p = .236). (See Table 9). A t-test was 
re-run after eliminating five outstanding outliers (1 male, 4 females). There was no 
significant difference between men and women in regard to their length of stay. 
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To examine the difference of men and women who died in the hospital, frequency 
distribution and chi-square were employed. Frequencies revealed that 1 male died and 5 
females died. (See Table 11). Due to the small number of subjects, chi-square criteria 
were not met, but results indicated that there is no significant gender difference (X2 = 
2.720, p = .09). 
Hypothesis 6 
“There is a gender difference in the coronary diagnostic and therapeutic 
procedures on patients with MI during hospitalization.” 
Frequency distribution and chi-square test were also utilized for the sixth 
hypothesis. The results indicated that men received coronary angiogram and coronary 
artery bypass graft (CABG) more often than women (91.3%, 21.0% vs 88.7%, 15.3%). 
Percutaneous transluminal coronary angioplasty (PTCA) was performed equally in both 
genders (53.3% vs 53.3%). There was no significant difference between men and women 
in regard to coronary angiogram (p =.441) and CABG (p = .179). (See Table 12). 
 
Other Findings 
A chi-square analysis was performed to examine the relationship of chest pain, 
morphine sulfate, and gender. Chest pain was a common symptom reported by both 
genders. However, men reported chest pain more often than women did. Morphine 
sulfate was given more often to men than to women (47.3% vs 33.3%, p = .013). (See 
Table 8). Overall, patients who reported chest pain received morphine sulfate more often 
than those patients who did not report chest pain (p = .000). Men who reported chest pain 
received morphine sulfate more than those men who did not report the symptom of chest 
pain in the emergency department (p = .005). Women who reported chest pain received 
morphine sulfate three times more often than those women who did not report chest pain 
(p = .013). (See Table 13). 
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Summary of Findings 
This chapter addressed the data analysis of gender differences in the presenting 
symptoms, treatment, and outcome of MI. Results of the statistical tests that were utilized 
in the present study for each of the six hypotheses were discussed as well as the reliability 
of the data collection tool.  
The description of the sample was presented. The age of the sample population 
ranged from 27 to 65 years old. The mean age of the total sample was 53.7 years old.  
Hypothesis one indicated that chest pain, shortness of breath, nausea, and left arm 
pain were the most commom symptoms of MI for both men and women in the emergency 
department. Men presented with chest pain more often than women (92% vs 83.3%, p = 
.022). Hypothesis two conveyed that there was not a significant difference in cardiac 
enzyme levels between women and men with MI, but there was a significant difference in 
the presence of Q waves between men and women. 
The third hypothesis indicated that a gender difference in the mean age of patients 
who experience their first MI exists. The mean age for women was 54.99 years and the 
mean age for men was 52.47 years (p = .004). Hypothesis four reflected that men 
received morphine sulfate more often than women (47.3% vs 33.3%, p = .013). 
Betablockers were also given more often to male patients than to female patients (24.0% 
vs 12.7%, p = .011). 
Hypothesis five reported that the mean length of stay in the hospital for men was 
6.48 days, and for women it was 7.17 days. The maximum length of stay for men was 25 
days versus 57 days for women. Furthermore, men had less than one percent chance of 
dying than women with MI (.7% vs 3.3%). The sixth hypothesis revealed that men 
received coronary angiogram and CABG more often than women (91.3%, 21.0% vs 
88.0%, 15.3%); however, the result was not significantly different. 
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The chapter concluded with a discussion of additional research findings. This 
study indicated that patients who reported chest pain received morphine sulfate more 
often than those patients who did not report chest pain (p = .000). Men who reported 
chest pain received morphine sulfate more than those men who did not report chest pain 
(p = .00479). Women who reported chest pain received morphine sulfate three times 
more than those women who did not have chest pain (p = .013). 
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CHAPTER VI 
 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
 
Introduction 
This chapter summarizes the study and discusses the significance of the study 
findings related to the six hypotheses and the conceptual framework. The limitations of 
the study, conclusions, implications for nursing, and recommendations for further study 
are discussed in the latter portion of the chapter.  
 
Summary of the Study 
The purposes of this study were to compare the differences in the presenting 
symptoms, treatment, and outcome of MI between men and women. The study sample 
consisted of 300 patients (N = 300) who were admitted to the emergency department at a 
county hospital in the Southwest area of the United States. Data were collected through 
chart review from January 1, 1998 to July 1, 2000. Frequency distributions, chi-square, 
and t-tests were used to analyze the study data.  
The present study found that chest pain, shortness of breath, sweating, and left 
arm pain were the most common symptoms on presentation for both men and women. 
However, men presented with chest pain more often than women did (92% vs 83.3%, p 
=.022). This study also found a difference in the electrographic changes between men and 
women. Men had more Q wave changes than their women counterparts (p = .019). There 
was no difference in the cardiac enzyme levels between both genders. The present study 
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also found that the average age for women who experience their first MI was two and a 
half years older than men. The most common treatments given to men and women in the 
emergency department were oxygen, nitrates, morphine sulfate, and heparin. A difference 
in the treatment between men and women as found in this study was that men received 
morphine sulfate and betablockers more often than women. Within this study, there was 
no significant difference in the length of stay in the hospital between men and women, no 
significant difference in coronary diagnostic and therapeutic procedures, or outcome 
between both genders.  
 
Discussion of the Findings 
Difference in the Presentation of MI 
The four most common symptoms on presentation for both men and women were 
chest pain, shortness of breath, sweating, and left arm pain. These findings are in 
concordance with those previously reported by Micevki (1996) where chest pain, 
shortness of breath, sweating, and left arm pain were the common symptoms presented 
by both genders. Penque et al. (1998) also found chest pain and shortness of breath as 
commom symptoms of MI in men and women. This indicates that chest pain continues to 
be a leading symptom of MI in both genders.  
Research studies on the different symptoms of MI experienced by men and 
women have been reported (Meischke et al., 1998; Micevski, 1996; Penque et al., 1998). 
This study found a significant difference regarding chest pain between men and women 
with MI. Ninety two percent of men presented more frequently with chest pain than 
83.3% of women. A possible explanation for this could be that a woman’s chest pain 
tends to be vaguer than the type of chest pain men experience (Margo & Penque, 1999). 
A woman may perceive pressure on the chest as pain; whereas, some health professionals 
may dismiss it as a sign of stress. Meischke et al. (1998) support the findings of this 
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study. Their study indicates that chest pain is reported more often in men than in women. 
However, their study found that women presented with more shortness of breath and 
nausea than men, which is not consistent with the findings of the present study. Penque et 
al. (1998) found that women reported with back pain, dyspnea, and loss of appetite more 
often than men, which is not in agreement with this study. A possible explanation for the 
inconsistencies in this study’s findings and with those reported by Meischke et al. (1998), 
Micevski (1996), and Penque et al. (1998) could be the quality of documentation by the 
individuals assessing the patient upon presentation in the emergency department. Another 
explanation could be the presence of gender bias on the part of health care practitioners 
who are more likely to interpret women’s complaints of chest pain or other symptoms as 
hypochondriacal behaviour (Rankin, 1997). In addition, the information in the chart may 
have been transcribed inaccurately (Mallory, 1997). 
Difference in the Cardiac Enzyme Levels and Electrographic Changes in MI 
A difference in the cardiac enzyme levels between men and women may have an 
impact on the treatment and management of MI. This study did not find a significant 
difference in the cardiac enzyme levels between men and women. A possible explanation 
for this could be that the cardiac enzyme levels after a myocardial infarction change 
overtime (Pagana & Pagana, 1990). The time frame for each patient's hospital admission 
and laboratory work-up may have been different. Another explanation could be that the 
sample of the present study was relatively small. Perhaps a larger population sample is 
needed to reflect enzymatic differences, if they exist.  
In this study, a difference in the electrographic changes between men and women 
who are experiencing MI in the emergency department was noted. Twenty one percent of 
men had more Q wave changes than 11.3% of their women counterparts (p = .019). A 
possible explanation for the difference in the electrocardiogram between men and women 
found in the present study could be that more men may have had a previous MI, or men 
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may have had a transmural infarction more often than women. Transmural infarcts (MI 
involving the three layers of the myocardium) are large enough to create an inscription of 
a Q wave on the electrocardiograph (McCance & Huether, 1998). One of the inclusion 
criteria for the present study was to include those patients who had their first MI; 
however, information on whether or not the patient had suffered a previous MI or had a 
transmural infarction was not always documented in the history and physical sheet or 
physician’s progress notes. The result of the present study on gender difference in the 
electrographic changes is not consistent with the study of Elhendy et al. (1999). In their 
research study, men had more ST-T abnormalities in the electrocardiogram than women 
with abnormal myocardial perfusion. The role of testosterone may be responsible for the 
difference on the electrographic pattern between men and women. Testosterone has a 
direct effect on the configuration and duration of ventricular repolarization (Bidoggia et 
al., 2000). Another possible explanation for the gender difference in the electrographic 
changes could be the difference in the cardiac anatomy of men and women. Women have 
smaller cardiac size and have diminutive coronary arteries (Beery, 1995; Khan et al., 
1990). 
Difference in the Mean Age of Patients with MI 
A difference in the mean age of patients who experience their first MI was found 
in this study. Women were older than men by two and a half years. This finding is 
consistent with the study of Marrugat et al. (1998). In their study, women were eight 
years older than men who experience their first MI. Thomas and Braus (1998) report that 
women develop coronary artery disease later in their life than men. A possible 
explanation could be the protective effect of estrogen in women. Until menopause, 
women have significantly less coronary heart disease than age-matched males due to the 
influence of estrogen on plasma lipoproteins by raising the high density lipoprotein and 
lowering the low density lipoprotein cholesterol (Flavell, 1994).  
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Difference in the Treatment of MI 
This study found that oxygen, nitrates, aspirin, morphine sulfate, and heparin 
were the most common treatments given to men and women in the emergency 
department. An explanation for this could be the facility’s protocol on the treatment of 
MI in which these medications, except heparin, are the treatments given to all patients 
who are experiencing MI, unless contraindicated. Gender difference in the management 
of patients with MI has also been the issue of current cardiovascular research. A 
difference in the treatment given to men and women in the emergency department was 
found in this study. Morphine sulfate and betablockers were given more often to men 
than women. This result is congruent with previous research studies on the difference in 
the treatment given to men and women with MI. Dellborg & Swedberg (1993); Marrugat 
et al., (1998) found that men received betablockers, nitroglycerin, and thrombolytics 
more frequently than women. In this study, morphine sulfate was administered more 
often to men than women. This is perhaps due to the higher frequency of chest pain in 
men than in women, as indicated in this study. The American College of 
Cardiology/American Heart Association Task Force (ACC/AHA) guidelines for the 
management of patients with MI suggest that betablocker therapy should be given to 
patients with evolving MI to reduce morbidity and mortality (Ryan et al., 1996). 
Although there are no studies that show men benefit more than women from betablocker 
therapy, in this study more men received betablockers than women in the emergency 
department. There are two possible explanations for this. One reason could be due to the 
individual’s physician’s subjective preference for the treatment of MI. Another reason 
could be the presence of gender bias as indicated in previous studies (Marrugat et al., 
1998; Yarzebski et al., 1996; Dellborg & Swedberg, 1993; Hsia, 1993).  
Difference in the Outcome of MI 
The present study found that there were no significant differences in the length of 
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stay in the hospital between men and women. The average length of stay for men was six 
days and seven days for women. Previous research shows that mortality in women is 
greater than in men during hospitalization following MI and that women who died were 
older than men (Marrugat et al., 1998; Vacarrino et al., 1998; Vacarrino et al., 1999; & 
Hochman et al., 1999). These findings are congruent with the frequencies found in the 
present study. There were more females who died in the hospital than males following 
MI (5 vs 1). Further research with a larger population sample and inclusion of older 
patients is warranted to determine whether the difference is statistically significant.  
Difference in the Coronary Diagnostic and Therapeutic Procedures 
In this study, there was no significant difference between men and women in 
regard to coronary angiogram, PTCA, and CABG. This finding is in contrast with 
previous research studies on gender bias in the management of MI. Men receive coronary 
angiogram, PTCA, and CABG more than their women counterparts (Steingart et al., 
1991; Dellborg & Swedberg, 1993; & Maynard et al., 1992). Women are referred for 
coronary angiogram, PTCA, and CABG later in the course of their disease (Eysman & 
Douglas, 1993; Khan et al., 1990). Again, further research is warranted. 
Relationship of Findings to the Neuman Systems Model 
The findings of this study support the Neuman’s Systems Model (1995). Stress 
and patient response to stress are two major components of this framework. Men and 
women’s flexible and normal lines of defenses have been disrupted by MI as manifested 
by their presenting symptoms. The study partially supports the fact that there is a 
difference between the male and female client system in regard to the stress response 
from MI. Chest pain, shortness of breath, sweating, and left arm pain were the most 
common stress responses reported by both genders in the present study. However, more 
men reported chest pain than women did. Neuman (1995) states that the recognition of 
the symptoms and initiation of treatment in the secondary prevention will strengthen the 
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patient’s lines of resistance and will prevent system instability or death. In this study, the 
common treatments given to men and women who are experiencing MI in the emergency 
department were oxygen, morphine sulfate, aspirin, nitrates, and heparin. More men 
received morphine sulfate and betablockers than women did. The recognition of the 
differing symptoms of men and women who are experiencing MI in secondary prevention 
is crucial. If symptoms are accurately recognized and appropriate treatments are 
provided, the patient’s lines of resistance will be strengthened, resulting in protection 
from further illness or death. 
 
Limitations of the Study 
The study results cannot be generalized to the overall population because the 
sample was drawn from only one hospital in one geographic area with a relatively small 
sample (N = 300). Risk factors for coronary artery disease were not addressed.  
A possible limitation of the study regards the information from the patient’s chart. 
Data obtained from the patient’s record may have been documented incorrectly or may 
have been influenced by the health care professional’s bias prior to or at the time of 
hospitalization. 
The Gender MI Data Collection Tool (GMIDCT) utilized in this study was 
developed by the researcher. Although the tool had an inter-rater reliability score of .97, 
it has not been tested in other studies, which possibly limits its reliability and validity for 
this study. Further research is needed with the use of the GMIDCT. 
 
Conclusions 
In light of the study’s findings and limitations, the following conclusions are 
presented for this population: 
1. Women experience less chest pain than men during MI. 
44 
 
2. Men present with Q wave changes more frequently than women with MI. 
3. A difference in the treatment of MI exists between men and women. Women 
     who are experiencing MI receive less morphine sulfate and betablockers than men. 
4. Women are older than men when they experience their first MI. 
5. Men and women who are hospitalized for MI undergo the same coronary 
    diagnostic and therapeutic procedures. 
 
Implications for Nursing 
Nurses are in the front line of interaction with patients presenting to the 
emergency department. Nurses’ knowledge regarding symptomatology of MI and its 
treatment and outcome can affect the plan of care for patients.  
The findings of this study can help nurses, nurse practitioners, and other health 
care providers in the care of MI patients. Health care professionals should be aware that 
gender bias in the treatment of MI is a possibility. They should also be cognizant that 
men and women may present with multiple or different symptoms of MI. Assessment and 
diagnosis of MI is more complex in women than in men, since their presentation patterns 
are usually more variable (Rankin, 1997). 
Based on the findings of this study, women may not report chest pain when 
experiencing MI. If women do not recognize their own presentation of MI as different 
from their partners or spouses, they may be less likely to report important clinical 
symptoms. Therefore, astute assessment by the nurses and the health care providers is 
crucial so that fair and more appropriate treatment will be provided to all patients 
experiencing a heart attack without gender bias. To reduce morbidity and mortality in 
women with MI, women should be treated exactly the same as men. 
 Nurses are in excellent position to educate patients and the public. Based on the 
findings of this study and those from previous research studies, nurses should educate 
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their patients on the symptoms of MI and the gender difference in the symptom 
presentation of MI. They should also advocate for more research to benefit the health of 
women and men. Although the risk factors for MI were not examined in this study, 
nurses should continue to provide routine teaching on their patients for the prevention of 
coronary artery disease. This would decrease mortality rates of men and women alike. 
 
Recommendations for Further Study 
Recommendations for further research studies are suggested based on the findings 
of this study: 
1. Replicate the present study using a larger population sample in more than one  
    hospital and from various geographical regions. 
2. Investigate gender difference of MI symptoms using patient questionnaires. 
3. Investigate possible differences in the perception of health care providers (such as 
emergency room staff nurses, nurse practitioners, physicians, and physician’s 
assistants) regarding the presenting symptoms, treatments, and outcome in MI between   
male and female patients. 
4. Examine women and men regarding their outcome after MI using a five-year 
longitudinal study. 
5. Compare the pharmacological treatments given to men and women during their     
hospitalization following MI in more than one hospital unit (such as in a coronary care 
unit and while in an intermediate care unit). 
6. Compare the cultural differences between men and women who have experienced 
their first MI. 
7. Examine women and men for the presence of risk factors for MI.  
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Summary 
Coronary heart disease continues to be the leading cause of death in men and 
women in the United States (American Heart Association, 1999). However, recent studies 
show that mortality in women is higher than in men following MI. Although this study 
did not show a significant difference in mortality between men and women, we should be 
aware that coronary heart disease is still the largest killer of women in the nation 
(American Heart Association, 1999). This study has shown that gender differences in the 
presentation and treatment of MI exist. Nurses and other health care professionals should 
be aware of the difference in the presenting symptoms of MI in men and women and they 
should also be alert to the presence of gender bias in the treatment of the disease. A fair 
treatment should be provided to both genders to minimize the morbidity and mortality 
from MI, especially in women.  
Research studies that focus on women’s cardiovascular health continue to be a 
challenge in the health care arena. As knowledge about women and heart disease 
increases, nurses and other health care professionals will gain new tools to combat and 
help prevent heart disease in women (Thomas & Braus, 1998). 
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-CARDIAC ENZYME LEVELS 
  Creatine Kinase, CKMB 
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 Figure 2. Application of the selected variables under study in the Neuman Systems 
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Table 1   Frequencies of Age of Patients with MI by Gender (N=300) 
 
Age in Years
Count Percent Count Percent
25-30 0 0.0% 1 0.7%
31-36 2 1.3% 2 1.3%
37-42 14 9.3% 8 5.3%
43-48 32 21.3% 17 11.3%
49-54 42 28.0% 31 20.7%
55-60 32 21.3% 48 32.0%
61-65 28 18.7% 43 28.7%
Frequencies
Men (n=150) Women (n=150)
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Table 2   Frequencies of Presenting Symptoms of Patients with MI by Gender (N=300) 
 
Variable
Count Percent Count Percent
pain in the center of the chest 138 92.0% 125 83.3%
shortness of breath 72 48.0% 74 49.3%
sweating 62 41.3% 56 37.3%
pain in L arm 60 40.0% 62 41.3%
nausea 46 30.7% 60 40.0%
pain spreading to shoulders 22 14.7% 14 9.3%
pain in the neck 18 12.0% 25 16.7%
pain in R arm 15 10.0% 20 13.3%
uncomfortable pressure 15 10.0% 16 10.7%
mid upper back pain/discomfort 8 5.3% 16 10.7%
lower back pain/discomfort 5 3.3% 9 6.0%
L jaw pain 5 3.3% 8 5.3%
Frequencies
Men (n=150) Women (n=150)
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Table 2 (cont)   Frequencies of Presenting Symptoms of Patients with MI by Gender 
(N=300) 
 
Variable
Count Percent Count Percent
chest discomfort with lightheadedness 5 3.3% 6 4.0%
R jaw pain 4 2.7% 5 3.3%
squeezing 1 0.7% 2 1.3%
abdominal pain/discomfort 0 0.0% 2 1.3%
intrascapular pain 0 0.0% 1 0.7%
fainting 0 0.0% 1 0.7%
fullness 0 0.0% 0 0.0%
other (vomiting, dizziness, weakness, cough) 41 27.3% 53 35.3%
Frequencies
Men (n=150) Women (n=150)
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Table 3   Chi-Square Results of Presenting Symptoms of Patients with MI by Gender 
(N=300) 
 
Variable X
2
Value (df=1) Level of Significance
uncomfortable pressure 0.036 0.850
fullness a
squeezing b 1.000
pain in the center of the chest 5.210 0.022
pain spreading to shoulders 2.020 0.155
pain in the neck 1.330 0.249
pain in R arm 0.809 0.369
pain in L arm 0.055 0.814
nausea 2.859 0.091
sweating 0.503 0.478
shortness of breath 0.053 0.817
fainting b 1.000
a. No statistics are computed because fullness is a constant.
b. Fisher's Exact Test computed because of low expected counts.
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Table 3 (cont)   Chi-square Results of Presenting Symptoms of Patients with MI by 
Gender (N=300) 
 
Variable X
2
Value (df=1) Level of Significance
chest discomfort with lightheadedness 0.094 0.759
intrascapular pain b 1.000
R jaw pain b 1.000
L jaw pain 0.724 0.395
mid upper back pain/discomfort 2.899 0.089
lower back pain/discomfort 1.199 0.274
abdominal pain/discomfort b 0.498
other (vomiting, dizziness, weakness, cough) 2.231 0.135
b. Fisher's Exact Test computed because of low expected counts.
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Table 4   T-test Results of Cardiac Enzyme Levels of Patients with MI by Gender 
(N=300) 
 
Variable N M SD
CK-MB levels
Men 150 42.324 107.760
Women 150 32.569 72.455
Variance t df Sig. (2-tailed)
Assumed Equal 0.920 298 0.358
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Table 5   Frequencies of Electrographic Changes in Patients with MI by Gender (N=300) 
 
Variable
Count Percent Count Percent
Q wave changes 32 21.3% 17 11.3%
ST segment changes 110 73.3% 117 78.0%
T wave changes 52 34.7% 50 33.3%
Frequencies
Men (n=150) Women (n=150)
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Table 6   Chi-Square Results of Electrographic Changes in Patients with MI by Gender 
(N=300) 
 
Variable X
2
Value (df=1) Level of Significance
Q wave changes 5.488 0.019
ST segment changes 0.887 0.346
T wave changes 0.059 0.807
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Table 7   T-test Results of Mean Age of Patients with MI by Gender (N=300) 
 
Variable N M SD
Age
Men 150 52.473 7.547
Women 150 54.987 7.568
Variance t df Sig. (2-tailed)
Assumed Equal -2.880 298 0.004
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Table 8   Frequencies of Treatment Received by Patients with MI by Gender (N=300) 
 
Variable
Count Percent Count Percent
Nitrates 136 90.7% 126 84.0%
Oxygen 132 88.0% 122 81.3%
Heparin 117 78.0% 108 72.0%
Aspirin 76 50.7% 61 40.7%
Morphine Sulfate 71 47.3% 50 33.3%
Thrombolytics 40 26.7% 35 23.3%
Beta blockers 36 24.0% 19 12.7%
Ace inhibitors 3 2.0% 0 0.0%
Frequencies
Men (n=150) Women (n=150)
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Table 9   Chi-Square Results of Treatment in Patients with MI by Gender (N=300) 
 
Variable X
2
Value (df=1) Level of Significance
Oxygen 2.568 0.109
Aspirin 3.023 0.082
Nitrates 3.013 0.083
Morphine Sulfate 6.108 0.013
Thrombolytics 0.444 0.505
Heparin 1.440 0.230
Beta blockers 6.434 0.011
Ace inhibitors a 0.247
a. Fisher's Exact Test computed because of low expected counts.
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Table 10   T-test Results of Outcome of Patients with MI by Gender (N=300) 
 
Variable N M SD
 Length of Stay
Men 150 6.487 3.612
Women 150 7.173 6.094
Variance t df Sig. (2-tailed)
Assumed Equal -1.187 298 0.236
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Table 11   Frequencies of Outcome in Patients with MI by Gender (N=300) 
 
Variable
Count Percent Count Percent
Death 1 0.7% 5 3.3%
Frequencies
Men (n=150) Women (n=150)
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Table 12   Frequencies of Coronary Diagnostic and Therapeutic Procedures in Patients 
with MI by Gender (N=300) 
 
Variable
Count Percent Count Percent
Coronary Angiogram 137 91.3% 133 88.7%
PTCA 80 53.3% 80 53.3%
CABG 32 21.3% 23 15.3%
Frequencies
Men (n=150) Women (n=150)
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Table 13   Frequencies and Chi-Square Results of Morphine Sulfate Treatment by Chest 
Pain Symptom in Patients with MI by Gender (N=300) 
 
Variable
Received Morphine Sulfate
Count Percent Count Percent
All subjects (n=121) 117 96.7% 4 3.3%
Men (n=71) 70 98.6% 1 1.4%
Women (n=50) 47 94.0% 3 6.0%
Variable X
2
Value (df=1) Level of Significance
Received Morphine Sulfate
All subjects 15.285 0.000
Men 7.958 0.005
Women 6.144 0.013
Frequencies
Chest Pain No Chest Pain
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APPENDIX C 
 
GENDER MI DATA COLLECTION TOOL 
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The Gender MI Data CollectionTool 
 
I. Demographics: 
1.  Identification Code: _________ 
2.  Gender: Male ___  Female ____ 
3.  Date of Admission: __________ 
4.  Date of Discharge: ___________ 
5.  Deceased: ____Yes   _____No 
6.  Age: ____ 
II. Cardiac Markers: 
1. Electrographic changes: (1=present, 0= not present) 
     Q wave        ____  
ST segment changes   ____   
T wave changes       ____  
2. Cardiac Enzymes: 
____ CKMB fraction  
III.   Presenting Symptoms: (1=present, 0=not present) 
     ___ uncomfortable pressure 
     ___ fullness 
     ___ squeezing 
     ___ pain in the center of the chest 
     ___ pain spreading to shoulders 
     ___ pain in the neck 
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      ___ pain in R arm 
      ___ pain in L arm 
      ___ nausea 
      ___ sweating 
      ___ shortness of breath 
      ___ fainting 
      ___ chest discomfort with lightheadedness 
      ___ intrascapular pain 
      ___ R jaw pain  
      ___ L jaw pain 
     ___ mid upper back pain/discomfort 
     ___ lower back pain/discomfort 
     ___ abdominal pain/discomfort 
     ___ other   
IV. Treatment Received:  (1=received, 0=not received) 
       ___ Oxygen 
     ___ Aspirin  
     ___ Nitrates  
     ___ Morphine Sulfate 
     ___ Thrombolytics 
     ___ Heparin 
     ___ Beta blockers 
     ___ Ace inhibitors 
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V.      Coronary Diagnostic and Therapeutic Procedures: (1 = received, 0= not received)                            
     ___ Coronary Angiogram 
     ___ PTCA 
     ___ CABG  
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